VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $853,026 | -42.1% | 91,038 | +51.7% | 0.05% | -40.5% |
| Q2 2023 | $1,472,021 | +7.0% | 60,009 | +1.5% | 0.08% | -7.1% |
| Q1 2023 | $1,375,234 | +312.7% | 59,099 | +348.8% | 0.08% | +286.4% |
| Q4 2022 | $333,257 | +28.7% | 13,167 | -1.8% | 0.02% | +15.8% |
| Q3 2022 | $259,000 | -24.7% | 13,412 | -0.6% | 0.02% | -13.6% |
| Q2 2022 | $344,000 | +22.4% | 13,495 | +23.7% | 0.02% | +83.3% |
| Q1 2022 | $281,000 | -44.6% | 10,911 | -9.9% | 0.01% | -29.4% |
| Q4 2021 | $507,000 | -14.5% | 12,107 | -11.1% | 0.02% | -15.0% |
| Q3 2021 | $593,000 | -4.2% | 13,620 | +4.1% | 0.02% | -4.8% |
| Q2 2021 | $619,000 | -8.0% | 13,083 | -0.3% | 0.02% | -19.2% |
| Q1 2021 | $673,000 | +74.8% | 13,126 | -8.7% | 0.03% | +52.9% |
| Q4 2020 | $385,000 | -13.7% | 14,379 | +10.6% | 0.02% | -26.1% |
| Q3 2020 | $446,000 | – | 13,002 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |